Evidence map›Paper›PMID 23720794›Full record

ArticleJournal of clinical microbiology2013

Use of Vitek 2 antimicrobial susceptibility profile to identify mecC in methicillin-resistant Staphylococcus aureus.

Edward J P Cartwright, Gavin K Paterson, Kathy E Raven, Ewan M Harrison, Theodore Gouliouris, Angela Kearns, Bruno Pichon, Giles Edwards, Robert L Skov, Anders R Larsen and 4 more

Abstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Prevalence ofBiomedicines · 2023
    Article
  6. Review
  7. HumanMicroorganisms · 2020
    Review
  8. Pathogens (Basel, Switzerland) · 2020
    Article
  9. Article
  10. Review
  11. Persistence and Diffusion ofFrontiers in microbiology · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Journal of clinical microbiology · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Detection ofJournal of clinical microbiology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Edward J P CartwrightDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Gavin K Paterson
Kathy E Raven
Ewan M Harrison
Theodore Gouliouris
Angela Kearns
Bruno Pichon
Giles Edwards
Robert L Skov
Anders R Larsen
Mark A Holmes
Julian Parkhill
Sharon J Peacock
M Estée Török

Funding

Biotechnology and Biological Sciences Research CouncilChief Scientist OfficeDepartment of HealthMedical Research Council G1000803Medical Research Council G1001787
6 · The paper itself

Abstract

The emergence of mecC methicillin-resistant Staphylococcus aureus (MRSA) poses a diagnostic challenge for clinical microbiology laboratories. Using the Vitek 2 system, we tested a panel of 896 Staphylococcus aureus isolates and found that an oxacillin-sensitive/cefoxitin-resistant profile had a sensitivity of 88.7% and a specificity of 99.5% for the identification of mecC MRSA isolates. The presence of the mecC gene, determined by bacterial whole-genome sequencing, was used as the gold standard. This profile could provide a zero-cost screening method for identification of mecC-positive MRSA strains.

Indexed as

HumansMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsSensitivity and Specificity

Identifiers

PMID23720794
PMCPMC3719650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.